| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |